Symbols / DNA Stock $8.44 +2.80% Ginkgo Bioworks Holdings, Inc.
DNA (Stock) Chart
About
No company description available for this symbol.
Stock Fundamentals
Scroll to Statements| Market Cap | 522.64M | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $8.21 | Price | $8.44 | Change | 2.80% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest DNA news- Ginkgo Bioworks (NYSE: DNA) officer sells shares to cover taxes after RSU vesting - Stock Titan Mon, 20 Apr 2026 21
- Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business - PR Newswire hu, 26 Feb 2026 08
- Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts - Yahoo Finance ue, 17 Feb 2026 08
- Best Genetic Sequencing Stocks for 2026 and How to Invest in Them - The Motley Fool Sun, 12 Apr 2026 07
- SONM (DNA X) tops Q3 2024 EPS forecasts, lifting shares nearly 10 percent on positive investor sentiment. - Real Time Stock Idea Network - UBND thành phố Hải Phòng hu, 23 Apr 2026 02
- Ginkgo Bioworks Makes Major Pivot (NYSE:DNA) - Seeking Alpha Mon, 02 Mar 2026 08
- Insider Sale: See remarks of $DNA Sells 13,116 Shares - Quiver Quantitative Fri, 10 Apr 2026 07
- Ginkgo Bioworks 10% owner Canton sells $175k in DNA stock - Investing.com Fri, 10 Apr 2026 07
- Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Sector with a Potential 9% Upside - DirectorsTalk Interviews Fri, 17 Apr 2026 09
- New research reveals how bacteria "selflessly" share DNA through GTAs - News-Medical hu, 16 Apr 2026 13
- DNA (NYSE: DNA) Form 144: Proposed sale of 324 Class A shares, insider sales listed - Stock Titan Fri, 17 Apr 2026 19
- Best Genomics Stocks for 2026 and How to Invest - The Motley Fool Sat, 18 Apr 2026 07
- $DNA stock is down 19% today. Here's what we see in our data. - Quiver Quantitative Fri, 27 Feb 2026 08
- A Look At Ginkgo Bioworks (DNA) Valuation After Earnings Update And Invaio Collaboration - Yahoo Finance Sun, 01 Mar 2026 08
- Ginkgo Bioworks (DNA) major shareholder sells $802k in stock - Investing.com Mon, 13 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
170.16
-25.06%
|
227.04
-9.71%
|
251.46
-47.36%
|
477.71
|
| Operating Revenue |
|
170.16
-25.06%
|
227.04
-9.71%
|
251.46
-47.36%
|
477.71
|
| Cost Of Revenue |
|
46.97
+5.44%
|
44.55
-17.51%
|
54.01
-73.55%
|
204.22
|
| Reconciled Cost Of Revenue |
|
46.97
+5.44%
|
44.55
-17.51%
|
54.01
-73.55%
|
204.22
|
| Gross Profit |
|
123.18
-32.50%
|
182.50
-7.57%
|
197.45
-27.80%
|
273.49
|
| Operating Expense |
|
427.06
-36.28%
|
670.22
-30.59%
|
965.65
-61.10%
|
2,482.44
|
| Research And Development |
|
243.77
-42.51%
|
424.06
-26.96%
|
580.62
-44.84%
|
1,052.64
|
| Selling General And Administration |
|
183.29
-25.54%
|
246.16
-36.07%
|
385.02
-73.07%
|
1,429.80
|
| General And Administrative Expense |
|
183.29
-25.54%
|
246.16
-36.07%
|
385.02
-73.07%
|
1,429.80
|
| Other Gand A |
|
183.29
-25.54%
|
246.16
-36.07%
|
385.02
-73.07%
|
1,429.80
|
| Total Expenses |
|
474.04
-33.68%
|
714.77
-29.90%
|
1,019.65
-62.05%
|
2,686.66
|
| Operating Income |
|
-303.88
+37.69%
|
-487.73
+36.51%
|
-768.20
+65.22%
|
-2,208.95
|
| Total Operating Income As Reported |
|
-315.28
+43.68%
|
-559.76
+35.24%
|
-864.41
+60.87%
|
-2,208.95
|
| EBITDA |
|
-254.61
+47.44%
|
-484.39
+41.10%
|
-822.34
+60.44%
|
-2,078.74
|
| Normalized EBITDA |
|
-226.80
+40.66%
|
-382.23
+39.71%
|
-633.97
+70.95%
|
-2,182.26
|
| Reconciled Depreciation |
|
58.99
-6.39%
|
63.02
-10.62%
|
70.51
+65.70%
|
42.55
|
| EBIT |
|
-313.60
+42.71%
|
-547.41
+38.69%
|
-892.85
+57.91%
|
-2,121.29
|
| Total Unusual Items |
|
-27.81
+72.78%
|
-102.17
+45.76%
|
-188.37
-281.96%
|
103.52
|
| Total Unusual Items Excluding Goodwill |
|
-27.81
+72.78%
|
-102.17
+45.76%
|
-188.37
-281.96%
|
103.52
|
| Special Income Charges |
|
-11.40
+85.58%
|
-79.04
+43.02%
|
-138.71
-534.98%
|
31.89
|
| Other Special Charges |
|
—
|
—
|
—
|
—
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
47.86
-50.26%
|
96.21
|
0.00
|
| Restructuring And Mergern Acquisition |
|
11.40
-52.85%
|
24.17
|
0.00
|
0.00
|
| Net Income |
|
-312.76
+42.83%
|
-547.03
+38.73%
|
-892.87
+57.58%
|
-2,104.93
|
| Pretax Income |
|
-313.60
+42.72%
|
-547.51
+38.68%
|
-892.94
+57.91%
|
-2,121.40
|
| Net Non Operating Interest Income Expense |
|
22.62
-41.28%
|
38.52
-32.57%
|
57.12
+183.41%
|
20.16
|
| Interest Expense Non Operating |
|
0.00
-100.00%
|
0.09
+1.08%
|
0.09
-12.26%
|
0.11
|
| Net Interest Income |
|
22.62
-41.28%
|
38.52
-32.57%
|
57.12
+183.41%
|
20.16
|
| Interest Expense |
|
0.00
-100.00%
|
0.09
+1.08%
|
0.09
-12.26%
|
0.11
|
| Interest Income Non Operating |
|
22.62
-41.43%
|
38.61
-32.52%
|
57.22
+182.39%
|
20.26
|
| Interest Income |
|
22.62
-41.43%
|
38.61
-32.52%
|
57.22
+182.39%
|
20.26
|
| Other Income Expense |
|
-32.34
+67.10%
|
-98.30
+45.95%
|
-181.87
-369.85%
|
67.40
|
| Other Non Operating Income Expenses |
|
-4.53
-216.98%
|
3.87
-57.65%
|
9.14
+19.70%
|
7.63
|
| Gain On Sale Of Security |
|
-16.41
+29.04%
|
-23.13
+53.43%
|
-49.66
-169.32%
|
71.64
|
| Gain On Sale Of Business |
|
0.00
+100.00%
|
-7.01
+83.50%
|
-42.50
-233.28%
|
31.89
|
| Tax Provision |
|
-0.84
-74.74%
|
-0.48
-574.65%
|
-0.07
+99.53%
|
-15.03
|
| Tax Rate For Calcs |
|
0.00
+200.00%
|
0.00
+1150.00%
|
0.00
-98.87%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.08
+18.34%
|
-0.10
-582.13%
|
-0.01
-102.04%
|
0.73
|
| Net Income Including Noncontrolling Interests |
|
-312.76
+42.83%
|
-547.03
+38.73%
|
-892.87
+57.61%
|
-2,106.37
|
| Net Income From Continuing Operation Net Minority Interest |
|
-312.76
+42.83%
|
-547.03
+38.73%
|
-892.87
+57.58%
|
-2,104.93
|
| Net Income From Continuing And Discontinued Operation |
|
-312.76
+42.83%
|
-547.03
+38.73%
|
-892.87
+57.58%
|
-2,104.93
|
| Net Income Continuous Operations |
|
-312.76
+42.83%
|
-547.03
+38.73%
|
-892.87
+57.61%
|
-2,106.37
|
| Minority Interests |
|
—
|
0.00
|
0.00
-100.00%
|
1.44
|
| Normalized Income |
|
-285.04
+35.94%
|
-444.96
+36.84%
|
-704.51
+68.09%
|
-2,207.72
|
| Net Income Common Stockholders |
|
-312.76
+42.83%
|
-547.03
+38.73%
|
-892.87
+57.58%
|
-2,104.93
|
| Otherunder Preferred Stock Dividend |
|
—
|
—
|
0.00
-100.00%
|
3.14
|
| Diluted EPS |
|
-5.64
+46.49%
|
-10.54
+42.62%
|
-18.37
+63.26%
|
-50.00
|
| Basic EPS |
|
-5.64
+46.49%
|
-10.54
+42.62%
|
-18.37
+63.26%
|
-50.00
|
| Basic Average Shares |
|
55.46
+6.87%
|
51.89
+6.76%
|
48.61
+15.80%
|
41.98
|
| Diluted Average Shares |
|
55.46
+6.87%
|
51.89
+6.76%
|
48.61
+15.75%
|
42.00
|
| Diluted NI Availto Com Stockholders |
|
-312.76
+42.83%
|
-547.03
+38.73%
|
-892.87
+57.58%
|
-2,104.93
|
| Earnings From Equity Interest |
|
0.00
|
0.00
+100.00%
|
-2.63
+93.98%
|
-43.76
|
| Line Item | Trend | 2023-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Assets |
|
1,665.34
|
—
|
| Current Assets |
|
1,001.75
|
—
|
| Cash Cash Equivalents And Short Term Investments |
|
944.07
|
—
|
| Cash And Cash Equivalents |
|
944.07
|
—
|
| Other Short Term Investments |
|
—
|
—
|
| Receivables |
|
17.90
|
—
|
| Accounts Receivable |
|
17.16
|
—
|
| Gross Accounts Receivable |
|
18.90
|
—
|
| Allowance For Doubtful Accounts Receivable |
|
-1.00
|
—
|
| Other Receivables |
|
1.55
-29.66%
|
2.20
|
| Loans Receivable |
|
—
|
11.56
|
| Inventory |
|
0.05
-98.63%
|
3.36
|
| Raw Materials |
|
—
|
0.06
|
| Work In Process |
|
—
|
0.05
|
| Finished Goods |
|
—
|
3.26
|
| Prepaid Assets |
|
20.74
+8.69%
|
19.08
|
| Restricted Cash |
|
4.79
|
0.00
|
| Other Current Assets |
|
39.78
|
—
|
| Total Non Current Assets |
|
663.59
|
—
|
| Net PPE |
|
394.99
|
—
|
| Gross PPE |
|
515.71
|
—
|
| Accumulated Depreciation |
|
-120.72
|
—
|
| Properties |
|
0.00
|
—
|
| Land And Improvements |
|
6.06
|
—
|
| Buildings And Improvements |
|
47.03
|
—
|
| Machinery Furniture Equipment |
|
21.24
|
—
|
| Construction In Progress |
|
15.83
|
—
|
| Other Properties |
|
353.99
|
—
|
| Leases |
|
71.56
|
—
|
| Goodwill And Other Intangible Assets |
|
131.98
|
—
|
| Goodwill |
|
49.24
+131.03%
|
21.31
|
| Other Intangible Assets |
|
82.74
|
—
|
| Investments And Advances |
|
77.91
|
—
|
| Long Term Equity Investment |
|
0.00
-100.00%
|
13.19
|
| Other Investments |
|
23.90
|
—
|
| Other Non Current Assets |
|
58.05
|
—
|
| Total Liabilities Net Minority Interest |
|
568.19
|
—
|
| Current Liabilities |
|
163.86
|
—
|
| Payables And Accrued Expenses |
|
43.51
|
—
|
| Payables |
|
9.32
|
—
|
| Accounts Payable |
|
9.32
|
—
|
| Current Accrued Expenses |
|
34.19
|
—
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
15.68
|
—
|
| Current Debt And Capital Lease Obligation |
|
17.47
|
—
|
| Current Capital Lease Obligation |
|
17.47
|
—
|
| Current Deferred Liabilities |
|
48.49
|
—
|
| Current Deferred Revenue |
|
48.49
|
—
|
| Other Current Liabilities |
|
38.70
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
404.33
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
221.84
|
—
|
| Long Term Capital Lease Obligation |
|
221.84
|
—
|
| Non Current Deferred Liabilities |
|
158.06
|
—
|
| Non Current Deferred Revenue |
|
158.06
|
—
|
| Other Non Current Liabilities |
|
24.43
|
—
|
| Stockholders Equity |
|
1,097.15
|
—
|
| Common Stock Equity |
|
1,097.15
|
—
|
| Capital Stock |
|
0.01
|
—
|
| Common Stock |
|
0.01
|
—
|
| Preferred Stock |
|
0.00
|
—
|
| Share Issued |
|
50.03
|
—
|
| Ordinary Shares Number |
|
50.03
|
—
|
| Treasury Shares Number |
|
0.00
-100.00%
|
79.60
|
| Additional Paid In Capital |
|
6,386.19
|
—
|
| Retained Earnings |
|
-5,290.53
|
—
|
| Gains Losses Not Affecting Retained Earnings |
|
1.48
|
—
|
| Minority Interest |
|
0.00
-100.00%
|
62.01
|
| Other Equity Adjustments |
|
1.48
|
—
|
| Total Equity Gross Minority Interest |
|
1,097.15
|
—
|
| Total Capitalization |
|
1,097.15
|
—
|
| Working Capital |
|
837.89
|
—
|
| Invested Capital |
|
1,097.15
|
—
|
| Total Debt |
|
239.31
|
—
|
| Capital Lease Obligations |
|
239.31
|
—
|
| Net Tangible Assets |
|
965.17
|
—
|
| Tangible Book Value |
|
965.17
|
—
|
| Available For Sale Securities |
|
54.01
|
—
|
| Derivative Product Liabilities |
|
5.70
-95.80%
|
135.84
|
| Duefrom Related Parties Current |
|
0.74
|
—
|
| Financial Assets |
|
0.65
|
—
|
| Inventories Adjustments Allowances |
|
—
|
-0.02
|
| Investmentin Financial Assets |
|
54.01
|
—
|
| Non Current Note Receivables |
|
13.60
|
0.00
|
| Notes Receivable |
|
12.29
+6.35%
|
11.56
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-171.06
+46.47%
|
-319.58
-8.15%
|
-295.50
-17.17%
|
-252.20
|
| Cash Flow From Continuing Operating Activities |
|
-171.06
+46.47%
|
-319.58
-8.15%
|
-295.50
-17.17%
|
-252.20
|
| Net Income From Continuing Operations |
|
-312.76
+42.83%
|
-547.03
+38.73%
|
-892.87
+57.61%
|
-2,106.37
|
| Depreciation Amortization Depletion |
|
58.99
-6.39%
|
63.02
-10.62%
|
70.51
+65.70%
|
42.55
|
| Depreciation |
|
—
|
—
|
71.55
+61.07%
|
44.42
|
| Depreciation And Amortization |
|
58.99
-6.39%
|
63.02
-10.62%
|
70.51
+65.70%
|
42.55
|
| Other Non Cash Items |
|
33.60
-36.87%
|
53.23
+4.57%
|
50.90
+574.28%
|
-10.73
|
| Stock Based Compensation |
|
81.55
-27.41%
|
112.34
-51.13%
|
229.88
-88.09%
|
1,930.64
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
58.48
-51.83%
|
121.40
|
0.00
|
| Deferred Tax |
|
-1.36
-45.73%
|
-0.94
-16.85%
|
-0.80
+94.52%
|
-14.61
|
| Deferred Income Tax |
|
-1.36
-45.73%
|
-0.94
-16.85%
|
-0.80
+94.52%
|
-14.61
|
| Operating Gains Losses |
|
16.41
-47.03%
|
30.98
-67.60%
|
95.64
+268.76%
|
-56.67
|
| Gain Loss On Investment Securities |
|
16.41
-29.04%
|
23.13
-53.43%
|
49.66
+169.32%
|
-71.64
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.84
+0.24%
|
0.84
-72.76%
|
3.09
|
| Change In Working Capital |
|
-44.09
+50.83%
|
-89.67
-400.53%
|
29.84
+180.63%
|
-37.01
|
| Change In Receivables |
|
-1.47
+68.83%
|
-4.72
-109.44%
|
50.07
-9.01%
|
55.02
|
| Changes In Account Receivables |
|
-1.47
+68.83%
|
-4.72
-109.44%
|
50.07
-9.01%
|
55.02
|
| Change In Inventory |
|
—
|
—
|
—
|
0.16
|
| Change In Prepaid Assets |
|
-5.25
-152.03%
|
10.09
-3.70%
|
10.47
+222.88%
|
-8.52
|
| Change In Payables And Accrued Expense |
|
7.38
+120.70%
|
-35.67
-326.95%
|
15.72
+131.13%
|
-50.48
|
| Change In Accrued Expense |
|
10.38
+125.66%
|
-40.44
-339.29%
|
16.90
+142.63%
|
-39.64
|
| Change In Payable |
|
-2.99
-162.71%
|
4.77
+503.30%
|
-1.18
+89.09%
|
-10.84
|
| Change In Account Payable |
|
-2.99
-162.71%
|
4.77
+503.30%
|
-1.18
+89.09%
|
-10.84
|
| Change In Other Working Capital |
|
-32.39
+52.81%
|
-68.64
-91.12%
|
-35.92
+1.37%
|
-36.42
|
| Change In Other Current Assets |
|
4.11
-81.38%
|
22.07
+86.31%
|
11.85
-16.31%
|
14.15
|
| Change In Other Current Liabilities |
|
-16.47
-28.79%
|
-12.79
+42.78%
|
-22.35
-107.68%
|
-10.76
|
| Investing Cash Flow |
|
-240.29
-286.09%
|
-62.24
+22.87%
|
-80.69
-19.73%
|
-67.39
|
| Cash Flow From Continuing Investing Activities |
|
-240.29
-286.09%
|
-62.24
+22.87%
|
-80.69
-19.73%
|
-67.39
|
| Net PPE Purchase And Sale |
|
-7.09
+88.54%
|
-61.89
-70.16%
|
-36.37
+30.41%
|
-52.27
|
| Purchase Of PPE |
|
-7.67
+87.74%
|
-62.54
-53.28%
|
-40.80
+21.94%
|
-52.27
|
| Sale Of PPE |
|
0.57
-11.42%
|
0.65
-85.37%
|
4.43
|
0.00
|
| Capital Expenditure |
|
-7.67
+87.74%
|
-62.54
-53.28%
|
-40.80
+21.94%
|
-52.27
|
| Net Investment Purchase And Sale |
|
-233.25
-5261.50%
|
4.52
|
0.00
+100.00%
|
-3.69
|
| Purchase Of Investment |
|
-418.63
|
0.00
|
0.00
+100.00%
|
-3.69
|
| Sale Of Investment |
|
185.38
+4002.28%
|
4.52
|
0.00
|
0.00
|
| Net Business Purchase And Sale |
|
0.00
+100.00%
|
-5.40
+87.44%
|
-42.98
-261.30%
|
26.65
|
| Purchase Of Business |
|
0.00
+100.00%
|
-5.40
+87.44%
|
-42.98
+22.87%
|
-55.72
|
| Gain Loss On Sale Of Business |
|
0.00
-100.00%
|
7.01
-83.50%
|
42.50
+233.28%
|
-31.89
|
| Net Other Investing Changes |
|
0.05
-90.71%
|
0.54
+140.15%
|
-1.34
+96.48%
|
-38.08
|
| Financing Cash Flow |
|
17.77
+1122.14%
|
-1.74
+45.93%
|
-3.22
-103.37%
|
95.34
|
| Cash Flow From Continuing Financing Activities |
|
17.77
+1122.14%
|
-1.74
+45.93%
|
-3.22
-103.37%
|
95.34
|
| Net Issuance Payments Of Debt |
|
-0.35
+60.54%
|
-0.90
+30.73%
|
-1.29
-4.69%
|
-1.24
|
| Repayment Of Debt |
|
-0.35
+60.54%
|
-0.90
+30.73%
|
-1.29
-4.69%
|
-1.24
|
| Long Term Debt Payments |
|
-0.35
+60.54%
|
-0.90
+30.73%
|
-1.29
-4.69%
|
-1.24
|
| Net Long Term Debt Issuance |
|
-0.35
+60.54%
|
-0.90
+30.73%
|
-1.29
-4.69%
|
-1.24
|
| Net Common Stock Issuance |
|
19.47
|
0.00
|
0.00
-100.00%
|
99.30
|
| Common Stock Payments |
|
—
|
—
|
0.00
|
0.00
|
| Repurchase Of Capital Stock |
|
—
|
—
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
0.08
-9.68%
|
0.09
-61.25%
|
0.24
|
| Net Other Financing Charges |
|
-1.34
-44.71%
|
-0.93
+54.02%
|
-2.01
+32.17%
|
-2.97
|
| Changes In Cash |
|
-393.57
-2.61%
|
-383.56
-1.09%
|
-379.41
-69.19%
|
-224.25
|
| Effect Of Exchange Rate Changes |
|
0.20
+171.53%
|
-0.28
+52.21%
|
-0.59
-164.76%
|
0.91
|
| Beginning Cash Position |
|
605.74
-38.79%
|
989.58
-27.75%
|
1,369.58
-14.02%
|
1,592.93
|
| End Cash Position |
|
212.37
-64.94%
|
605.74
-38.79%
|
989.58
-27.75%
|
1,369.58
|
| Free Cash Flow |
|
-178.72
+53.23%
|
-382.13
-13.63%
|
-336.30
-10.45%
|
-304.47
|
| Interest Paid Supplemental Data |
|
0.00
-87.50%
|
0.03
-61.45%
|
0.08
-9.78%
|
0.09
|
| Income Tax Paid Supplemental Data |
|
0.19
-78.52%
|
0.89
+33.43%
|
0.67
|
0.00
|
| Amortization Of Securities |
|
-3.39
|
0.00
|
0.00
|
—
|
| Common Stock Issuance |
|
19.47
|
0.00
|
0.00
-100.00%
|
99.30
|
| Earnings Losses From Equity Investments |
|
0.00
|
0.00
-100.00%
|
2.63
-93.98%
|
43.76
|
| Issuance Of Capital Stock |
|
19.47
|
0.00
|
0.00
-100.00%
|
99.30
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Sale Of Business |
|
—
|
—
|
—
|
82.37
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-20 View
- 42026-04-14 View
- 42026-04-13 View
- 42026-04-13 View
- 42026-04-10 View
- 42026-04-10 View
- 42026-04-10 View
- 8-K2026-04-07 View
- 42026-03-18 View
- 8-K2026-02-27 View
- 10-K2026-02-26 View
- 8-K2026-02-26 View
- 42026-01-22 View
- 8-K2025-12-23 View
- 42025-12-16 View
- 10-Q2025-11-06 View
- 8-K2025-11-06 View
- 42025-10-21 View
- 42025-10-03 View
- 42025-09-10 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|